About The Medical Condition EN-1639A
Find the definition of the medical term EN-1639A. EN-1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN-1639A
| EN-1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN-1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Carbenicillin Disodium ‐ Broad-spectrum semisynthetic penicillin derivative used parenterally.…
- Traumatology ‐ The branch of surgery which deals with wounds and disability…
- Newspaper Article ‐ A news item printed in a general-interest newspaper or other…
- Hemorrhage, Traumatic Brainstem ‐ Extravasation of blood into the midbrain, pons, or medulla following…
- Hydrochloride, Impromidine ‐ A highly potent and specific histamine H2 receptor agonist. It…
- Agonist, gamma-Aminobutyric Acid ‐ Drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors…
- House Staffs ‐ Programs of training in medicine and medical specialties offered…
- Junctions, Gap ‐ Connections between cells which allow passage of small molecules…
- Curettage, Gingival ‐ Removal of degenerated and necrotic epithelium and underlying…
- Oncolytic Virus ‐ Minute infectious agents whose genomes are composed of DNA or…